Current Pharmaceutical Design
Title: Editorial [Hot Topic: Nutraceuticals and Prevention of Neurodegeneration (Executive Guest Editors: Thea Magrone and Emilio Jirillo)]
Volume: 18 Issue: 1
Author(s): Thea Magrone and Emilio Jirillo
Affiliation:
Export Options
About this article
Cite this article as:
Magrone Thea and Jirillo Emilio, Editorial [Hot Topic: Nutraceuticals and Prevention of Neurodegeneration (Executive Guest Editors: Thea Magrone and Emilio Jirillo)], Current Pharmaceutical Design 2012; 18 (1) . https://dx.doi.org/10.2174/138161212798919066
DOI https://dx.doi.org/10.2174/138161212798919066 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Risk Assessment of the Use of Autonomous Parvovirus-Based Vectors
Current Gene Therapy P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update
Current Drug Metabolism Pathogenesis of HIV-Associated Non-Hodgkin Lymphoma
Current HIV Research Synergistic Activities of a Silver(I) Glutamic Acid Complex and Reactive Oxygen Species (ROS): A Novel Antimicrobial and Chemotherapeutic Agent
Current Medicinal Chemistry Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Meeting Report: The Fourth Annual PepTalk Meeting: The Human Proteome
Current Proteomics Personalized Medicine for Glioblastoma: Current Challenges and Future Opportunities
Current Molecular Medicine Synthetic Peptides As Non-Viral DNA Vectors
Current Gene Therapy A Reliable HPLC Method for Monitoring Midazolam Plasma Levels in Critically Ill Pediatric Patients
Current Pharmaceutical Analysis Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research Signaling Pathways of the ING Proteins in Apoptosis
Current Drug Targets Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery
Current Pharmaceutical Design Hematological Targets of Radiation Damage
Current Drug Targets Potentials of Polymeric Nanoparticle as Drug Carrier for Cancer Therapy: With a Special Reference to Pharmacokinetic Parameters
Current Drug Metabolism miR-149 as a Potential Molecular Target for Cancer
Current Medicinal Chemistry Cilostazol as a Unique Antithrombotic Agent
Current Pharmaceutical Design Advances in Photodynamic Therapy Assisted by Electroporation
Current Drug Metabolism Synthetic Approaches to Various Class of Topoisomerase II Inhibitors
Mini-Reviews in Organic Chemistry Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry